Preparation of analogues of efaroxan and KU14R as potential imidazoline receptor subtype 3 ligands

Journal of Heterocyclic Chemistry

Volumn 45, Issue 3, 2008, Pages 887-896

  Farn, Richard D ^a   Morgan, Noel G ^a,b   Ramsden, Christopher A ^a  

^a KEELE UNIVERSITY   (United Kingdom)

^b PENINSULA MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2',3' DIHYDRO 2' ETHYLBENZO[B]FURAN 2' YL) 1,4,5,6 TETRAHYDROPYRIMIDINE; 2 (2',3' DIHYDRO 2' ETHYLBENZO[B]FURAN 2' YL) 5 ETHYL SULFANYL [1,3,4]OXADIAZOLE; 2 (2',3' DIHYDRO 2' ETHYLBENZO[B]FURAN 2' YL) 5 METHYL SULFANYL [1,3,4]OXADIAZOLE; 2 (2',3' DIHYDRO 2' ETHYLBENZO[B]FURAN 2' YL) 5,5 DIMETHYL 1,4,5,6 TETRAHYDROPYRIMIDINE; 2 (2,3 DIHYDRO 2 ETHYLBENZO[B]FURAN 2 YL) 5 AMINO PYRIMIDINE; 2 (2,3 DIHYDRO 2 ETHYLBENZO[B]FURAN 2 YL) 5 NITRO PYRIMIDINE; 2 [5 (2',3' DIHYDRO 2' ETHYLBENZO[B]FURAN 2' YL) [1,3,4] OXADIAZOL 2 YLSULFANYL]ACETIC ACID; 2 ETHYL 3 FLUORO 2,3 DIHYDRO 1 BENZO[B]FURAN 2 CARBONITRILE; 2 ETHYL 3 HYDROXY 2,3 DIHYDRO 1 BENZO[B]FURAN 2 CARBONITRILE; 2 ETHYL 3 OXO 2,3 DIHYDRO 1 BENZO[B]FURAN 2 CARBONITRILE; 2,3 DIHYDRO 2 ETHYLBENZO[B]FURAN 2 CARBOXAMIDINE HYDROCHLORIDE; 2,3 DIHYDRO 2 ETHYLBENZO[B]FURAN 2 CARBOXYLIC ACID DIMETHYLAMINOMETHYLENEAMIDE; 2,3 DIHYDRO 2 ETHYLBENZO[B]FURAN 2 CARBOXYLIC ACID HYDRAZIDE; 2,3 DIHYDRO 2 ETHYLBENZO[B]FURAN 2 CARBOXYLIC ACID HYDROXY IMINOMETHYLAMIDE; 2,3 DIHYDRO 2 ETHYLBENZO[B]FURAN 2 CARBOXYLIC ACID HYDROXYAMINOMETHYLENEAMIDE; 2,3 DIHYDRO 2 ETHYLBENZO[B]FURAN 2 CARBOXYLIC ACID PROPYLAMIDE; 2,3 DIHYDRO 3 (1',3' DIOXALAN 2' YL) 2 ETHYLBENZO [B]FURAN 2 CARBONITRILE; 3 (2,3 DIHYDRO 2 ETHYLBENZO[B]FURAN 2 YL) 4H [1,2,4] TRIAZOLE; 3,3 DIBROMO 2,3 DIHYDRO 2 ETHYLBENZO[B]FURAN 2 CARBONITRILE; 3,6 BIS (2',3' DIHYDRO 2' ETHYLBENZO[B]FURAN 2' YL) 1,2 DIHYDRO 1,2,4,5 TETRAZINE; 5 (2,3 DIHYDRO 2 ETHYLBENZO[B]FURAN 2 YL) 3H [1,3,4] OXADIAZOLE 2 THIONE; EFAROXAN; IMIDAZOLINE DERIVATIVE; METHYL 2 [5 (2',3' DIHYDRO 2' ETHYLBENZO[B]FURAN 2' YL) [1,3,4] OXADIAZOL 2 YLSULFANYL]ACETATE; METHYL 2,3 DIHYDRO 2 ETHYLBENZO[B]FURAN 2 CARBOXIMIDATE; METHYL 2,3 DIHYDRO 2 ETHYLBENZO[B]FURAN 2 CARBOXYLATE;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL REACTION; CHEMICAL STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; SYNTHESIS;

EID: 44349136326     PISSN: 0022152X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jhet.5570450338     Document Type: Article

References (16)

1. Chan, S. L. F.; Pallett, A. L.; Clews, J.; Ramsden, C. A.; Chapman, J. C.; Kane, C.; Dunne, M. J.; Morgan, N. G. Eur. J. Pharmacol 1998, 355, 67.
2. Monks, L. K.; Cosgrove, K. E.; Dunne, M. J.; Ramsden, C. A.; Morgan, N. G.; Chan, S. L. F. FEBS Lett. 1999, 447, 61.
3. Morgan, N. G.; Chan, S. L. F. Drug Design Rev. Online, 2004, 1, 185.
4. Chan, S. L. F.; Mourtada, M.; Morgan, N. G. Diabetes, 2001, 50, 340.
5. Morgan, N. G.; Chan, S. L. F.; Mourtada, M.; Monks, L. K.; Ramsden C. A. Ann. N. Y. Acad. Sci. 1999, 881, 217.
6. Eglen, R. M.; Hudson, A. L.; Kendall, D. A.; Nutt, D. J.; Morgan, N. C.; Wilson, V. G.; Dillon, M. P. Trends Pharmacol Sci. 1998, 19, 381.
7. Clews, J.; Morgan, N. G.; Ramsden, C. A. Synthesis, 2001, 1546.
8. Bleck, C.; Wienbergen, A.; Rustenbeck, I. Diabetologia, 2005, 48, 2567.
9. Squires, P. E.; Hills, C. E.; Rogers, G. J.; Garland, P.; Farley, S. R.; Morgan, N. G. Eur. J. Pharmacol 2004, 501, 31.
10. [101 Chan, S. L. F.; Atlas, D.; James, R. F. L.; Morgan, N. G. Br. J. Pharmacol. 1997, 120, 926.
11. Mayer, G.; Taberner, P. V. Eur J Pharmacol. 2002, 454, 95.
12. Lin, Y.-I.; Lang, S. A.; Lovell, M. F.; Perkinson, N. A. J. Org. Chem. 1979, 44, 4160.
13. Edwards, C. R.; Readhead, M. J.; Tweddle, N. J. J. Heterocycl. Chem. 1987, 24, 495.
14. Clews, J.; Morgan, N. G.; Ramsden, C. A. J. Heterocycl. Chem. 2001, 38, 519.
15. Fanta, P. E. Org. Synth. 1952, 32, 95.
16. Fanta, P. E.; Hedman, E. A. J. Am. Chem. Soc. 1956, 78, 1434.